the effect of distraction in the treatment of knee arthrosis
- Conditions
- knee osteoarthritis.Primary arthrosis NOS
- Registration Number
- IRCT201111214738N2
- Lead Sponsor
- Shahid Bbeheshti University of Medical Sciences, Vice Chancellor for Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 20
Female patients with sever knee OA (grade 3&4 Kalgren Lawrence scale) with the age range between 45 and 75.
Exclusion criteria :
malignancy in knee joint, infection around the knee joint, metabolic disease, endocrine disorders, vascular disease, injection of corticosteroid in the last 30 days, recent start of use of anti-inflammatory medicine (in the last 30 days), open injuries in the knee, secondary osteoarthritis, history of knee fractures, surgery in the knee joint in the last 6 months, pain duration less than 1 year, knee joint hypermobility and ligamentus laxity, sever edema around the knee joint and psychological disorders.
- Feel of pain in the chest, breathlessness, leg cramps, tumbling, sever perspiration and pale appearance and inability for finishing the 6 minute walking test.
-Absence in two successive treatment sessions.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Functional ability. Timepoint: in the 1st session, 10th session and 1 month after treatment ends. Method of measurement: by 6 minute walking test.;Amount of pain. Timepoint: in 1st to 10th session and 1 month after treatment ends. Method of measurement: by VAS measurement.;Amount of joint effusion. Timepoint: in 1st to 10th session and 1 month after treatment ends. Method of measurement: by measurement tape over and 10 cm above and bellow knee joint line.;Knee joint mobility. Timepoint: in 1st to 10th session and 1 month after treatment ends. Method of measurement: by goniometer.
- Secondary Outcome Measures
Name Time Method Quality of life. Timepoint: in 1st and 10th session and 1 month after treatment ends. Method of measurement: questionnaire.